U.S. approves first marijuana plant-derived drug for epilepsy

(Reuters) - GW Pharmaceuticals Plc's epilepsy treatment on Monday secured an approval from the U.S. Food and Drug Administration, becoming the first cannabis-based drug to be approved in the country.